|
WDR41 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.92570000021742E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.72989999999551E-05 |
| Normal-vs-Stage2 |
6.784900E-04 |
| Normal-vs-Stage3 |
2.808900E-04 |
| Normal-vs-Stage4 |
1.171750E-04 |
| Stage1-vs-Stage2 |
3.615800E-01 |
| Stage1-vs-Stage3 |
9.456000E-01 |
| Stage1-vs-Stage4 |
4.636800E-01 |
| Stage2-vs-Stage3 |
3.506200E-01 |
| Stage2-vs-Stage4 |
7.242400E-01 |
| Stage3-vs-Stage4 |
5.144800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.13439999954923E-07 |
| Normal-vs-AfricanAmerican |
1.000170E-01 |
| Normal-vs-Asian |
1.200240E-01 |
| Caucasian-vs-AfricanAmerican |
8.497700E-03 |
| Caucasian-vs-Asian |
8.155800E-01 |
| AfricanAmerican-vs-Asian |
4.555000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.6028000001459E-07 |
| Normal-vs-Female |
1.639350E-04 |
| Male-vs-Female |
4.510200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.906300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.049800E-04 |
| Normal-vs-Age(61-80Yrs) |
2.0192000005359E-07 |
| Normal-vs-Age(81-100Yrs) |
1.238040E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.476200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.801400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.558000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.333800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.050800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.442600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.696200E-01 |
| Normal-vs-Grade 2 |
2.27250000000012E-05 |
| Normal-vs-Grade 3 |
2.03399999999521E-05 |
| Normal-vs-Grade 4 |
1.647890E-04 |
| Grade 1-vs-Grade 2 |
1.680400E-02 |
| Grade 1-vs-Grade 3 |
2.082100E-02 |
| Grade 1-vs-Grade 4 |
1.698410E-02 |
| Grade 2-vs-Grade 3 |
9.249800E-01 |
| Grade 2-vs-Grade 4 |
6.514000E-01 |
| Grade 3-vs-Grade 4 |
6.341600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.77243999999188E-05 |
| Normal-vs-ccB subtype |
1.29159999995299E-06 |
| ccA subtype-vs-ccB subtype |
5.154600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.60429999968615E-07 |
| Normal-vs-N1 |
3.501600E-02 |
| N0-vs-N1 |
5.026400E-01 |
|
|
